SEC Form 4 · accession 0001209191-19-015110
EXACT SCIENCES CORP · EXAS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin T Conroy
Officer — President and CEO · Director
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124140
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2019 | S | 10,014 | $93.204 | D | 925,353 | D | |
| Common Stock | holding | — | — | — | 25,913 | I | Held in 401(K) Plan | |
| Common Stock | holding | — | — | — | 65,189 | I | Held in Grantor Retained Annuity Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2019.
- F2In addition to the shares of Common Stock reported on this Form 4, which total 1,016,455 shares, Mr. Conroy also holds, in the aggregate, an additional 1,173,941 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.